Effect of adjuvant therapy on development of diabetes in mouse and man
- PMID: 7907682
- DOI: 10.1016/s0140-6736(94)91583-0
Effect of adjuvant therapy on development of diabetes in mouse and man
Erratum in
- Lancet. 2006 Apr 15;367(9518):1240. Bruchlim, I [corrected to Bruchim, I]
Abstract
Freund's complete adjuvant (CFA) and BCG vaccine modulate the development of type 1 diabetes in animal models. In non-obese diabetic mice, CFA and BCG significantly reduced the proportion developing diabetes compared with controls. Histological examination showed that autoimmune disease still developed but had been diverted to become nondestructive. In a preliminary trial in 17 newly diagnosed, type 1 diabetic patients, intracutaneous administration of 0.1 mL of BCG 1 mg/mL led to clinical remission in 11 (65%)--by week 4 in 6. Remission has been sustained in 3 for 6-10 months. No side-effects were reported. A double-blind trial of BCG is warranted.
Comment in
-
IDDM: long honeymoon, sweet ending.Lancet. 1994 Mar 19;343(8899):684-5. doi: 10.1016/s0140-6736(94)91574-1. Lancet. 1994. PMID: 7907674 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical